Tonix Pharmaceuticals CEO Acquires $20,275 in Common Shares
Tonix Pharmaceuticals CEO Seth Lederman acquired $20,275 in common shares.
Related stories
Nvidia Appoints Colette Kress Interim CEO, Harvey C. Jones Board Chair
M impact | EQUITY | Nov 12, 2026, 01:53 PM UTC
Jensen Huang Resigns as Nvidia Chairman, CEO and Board Member
Nvidia says Jensen Huang has resigned as chairman, chief executive and a member of the board, effective immediately.
M impact | EQUITY | Nov 12, 2026, 01:52 PM UTC
Fincantieri Signs €1.80 Billion Contract for Two Destroyers
Fincantieri signed a €1.80 billion contract for two DDX destroyers for the Italian Navy.
M impact | EQUITY | Nov 12, 2026, 01:52 PM UTC
HubSpot Co-Founder Brian Halligan Returns as CEO; Yamini Rangan Departs
HubSpot said Yamini Rangan has stepped down as an executive and board member, and co-founder Brian Halligan is returning to lead the company.
L impact | EQUITY | Nov 12, 2026, 01:52 PM UTC
Wall Street Futures Point Lower After Nvidia Rout and Oil Gains
Wall Street's main indexes were set to open lower Thursday as Nvidia-related concerns and higher oil prices weighed on sentiment.
M impact | EQUITY | Nov 12, 2026, 01:52 PM UTC
NVIDIA CEO Jensen Huang Resigns Immediately
M impact | EQUITY | Nov 12, 2026, 01:51 PM UTC